John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 44,456 shares at $6.11 ($271K) on 2022-06-15, disclosed to the SEC on 2022-06-15.
Open-market sale of $271k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.01 | 4,093 | $25K | 9.1% |
| 2 | $6.02 | 3,628 | $22K | 8.1% |
| 3 | $6.11 | 585 | $4K | 1.3% |
| 4 | $6.11 | 18,075 | $110K | 40.8% |
| 5 | $6.11 | 18,075 | $110K | 40.8% |
| Total | $6.09 avg | 44,456 |
| $271K |
| 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |